Boehringer Ingelheim/Glaxo Wellcome kooperieren

Article Abstract:

German Boehringer Ingelheim Pharma KG and the German subsidiary of Glaxo Wellcome of the UK have agreed upon cooperation in the marketing of cardiovascular drugs. The first product to be marketed jointly on the German market is lacidipin (Motens) against hypertension from 1 June 1998. Moreover, the two companies are to carry out clinical tests with telmisartan, an angiotensin II antagonist against hypertension. *

Comment:

German subsidiary agrees w/ Boehringer Ingelheim Pharma upon cooperation in the marketing of cardiovascular drugs

Strategic alliances, Cardiovascular Preparations, Glaxo Wellcome PLC, Cardiovascular agents, Boehringer Ingelheim Pharma KG

---

Boehringer Ingelheim investiert in Italien

Article Abstract:

In 1998, Boehringer Ingelheim Italia SpA, subsidiary of the German pharmaceutical company, is to double the production of fluids and suppositories in Reggello to 2.08mn packs. Investments in the last three years amounted to L 50bn. Another L 15bn is to be invested in Fornovo San Giovanni in the next four to five years. In 1997, turnover of Boehringer Ingelheim Italia increased by 12% to L 364.3bn.

Comment:

Will double production of fluids & suppositories in Reggello, Italy, to 2.08 mil packs

Italy, Production data, Boehringer Ingelheim S.p.A.

---

GERMANY/US: BOEHRINGER INGELHEIM, GENETRONICS

Article Abstract:

Boehringer Ingelheim GmbH of Germany and Genetronics of San Diego, California, have signed an 18-month cooperation agreement. The two companies are to develop Genetronics' electrophoration technology for gene technology applications. With electrodes to be developed by Genetronics, active agents or genes are to be injected into cells to treat cancer.

United States, Drugs & Pharmaceuticals, Biochemistry, Pharmaceutical and Medicine Manufacturing, Research and Development in the Physical, Engineering, and Life Sciences, Research & development outlays, Medical Instruments & Equipment, Medical Equipment and Supplies Manufacturing, Carbon and Graphite Product Manufacturing, Graphite & Carbon Electrodes, Statistical Data Included, Drugs, Medical equipment, Electrodes, Boehringer Ingelheim Group, Boehringer Ingelheim GmbH

Similar abstracts:

• Abstracts: Protein-beta-ionone ring interactions enhance the light-induced dipole of the chromophore in bacteriorhodospin
• Abstracts: Two-dimensional lipid mixing entropy regulates the formation of multicomponent lipoplexes. Structural and phase behavior of self-assembled DPPC-DNA-metal cation complexes
• Abstracts: ZaCh System to buy PPG fine chemicals. Axyntis: a new name emerges in French fine chemicals and dyes. ICIG buys Clariant Custom Manufacturing business
• Abstracts: Probing paeonol-Puronic polymer interactions by [super 1]H NMR spectroscopy. Effect of ionic liquids on the aggregation behavior of PEO-PPO-PEO block copolymers in aqueous solution
• Abstracts: Origin of the anomalous two-photon absorption in fluorescent protein DsRed. Predictions of novel two-photon absorption bands in fluorescent proteins

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.